[HTML][HTML] Bioavailability enhancement of curcumin via esterification processes: A review

N Agrawal, M Jaiswal - European Journal of Medicinal Chemistry Reports, 2022 - Elsevier
Turmeric (Curcuma longa) has been used in the form of kitchen spices since ancient times. It
is a traditional medicine of Ayurveda and Chinese medicine in which curcuminoids are …

Recent advances of curcumin derivatives in breast cancer

Y Yin, Y Tan, X Wei, X Li, H Chen, Z Yang… - Chemistry & …, 2022 - Wiley Online Library
Curcumin is a potential plant‐derived drug for the treatment of breast cancer. Poor solubility
and bioavailability are the main factors that limit its clinical application. Various structural …

Bioactive compounds, antibacterial and antioxidant activities of methanol extract of Tamarindus indica Linn.

KO Fagbemi, DA Aina, MO Adeoye-Isijola, KK Naidoo… - Scientific reports, 2022 - nature.com
Tamarindus indica is one of the tropical medicinal plants that has been attributed curative
potential of numerous diseases by many rural dwellers. This study was designed to evaluate …

Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines

S Taurin, RJ Rosengren - Medical Oncology, 2022 - Springer
Triple-negative breast cancers (TNBCs) are characterized by a lack of approved targeted
therapies and remain a challenge in the clinic. Several overexpressed proteins, including …

[PDF][PDF] Investigating the Effect of Loading Curcuminoids Using PCL-PU-βCD Nano-Composites on Physico-Chemical Properties, In-Vitro Release, and Ex-Vivo Breast …

SA Abou Taleb, RA Sobh… - Biointerface Res. Appl …, 2022 - biointerfaceresearch.com
Recently, cancer is deemed the main reason for death. Although most anti-cancer drugs
have potent anti-cancer activity, their applications are greatly obstructed due to their flimsy …

Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer

H Palmer, M Nimick, A Mazumder, S Taurin, Z Rana… - Biomedicines, 2022 - mdpi.com
Androgen receptor (AR)-castrate-resistant prostate cancer (CRPC) is an aggressive form of
prostate cancer that does not have clinically approved targeted treatment options. To this …